Clinical trial · Interventional
Topical Vitamin C for Treatment of Basal Cell Cancer
Topical Ascorbic Acid for Treatment of Basal Cell Carcinoma
NCT04279535CI-TRIAL-00054803completedEarly Phase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Topical Ascorbic Acid | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- ascorbic acid
- description
- Participants applied topical solution of ascorbic acid twice daily for 8 weeks
- interventionNames
- Drug: Topical Ascorbic Acid
- type
- ACTIVE_COMPARATOR
- label
- Imiquimod
- description
- Participants applied 5% imiquimod cream topically 5x/week
- interventionNames
- Drug: Topical Ascorbic Acid
Primary outcomes (1)
- measure
- Lesion Resolution
- timeFrame
- 8 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Presence of biopsy proven basal cell carcinoma Exclusion Criteria: * Absence of basal cell carcinoma
References
Publications (0)
Data not yet available
No reference posted for this study.